Literature DB >> 6292500

Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma.

L Gissmann, V Diehl, H J Schultz-Coulon, H zur Hausen.   

Abstract

Papilloma virus DNA from a laryngeal papilloma was cloned in phage lambda L 47 and characterized after cleavage with different restriction enzymes. Hybridization with the DNAs of human papilloma virus types 1, 2, 3, 4, 5, and 8 showed no homology under stringent hybridization conditions. Human papilloma virus type 6 DNA, however, was partially identical to laryngeal papilloma virus DNA; different restriction enzyme fragments hybridizing with the other DNA were identified on each genome. The degree of homology was determined by reassociation kinetics to be 25%. According to the present nomenclature, laryngeal papilloma virus therefore represents a different type of human papilloma virus and is tentatively designated as human papilloma virus type 11. Sequences homologous to laryngeal papilloma virus DNA were also found in four of nine additional laryngeal papillomas. Attempt to detect homologous DNA in 12 carcinomas of the larynx were negative.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292500      PMCID: PMC256274     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets.

Authors:  H Wolf; J Werner; H zur Hausen
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

3.  Electron microscopic identification of papova virus in laryngeal papilloma.

Authors:  W F Boyle; J L Riggs; L S Oshiro; E H Lennette
Journal:  Laryngoscope       Date:  1973-07       Impact factor: 3.325

4.  Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.

Authors:  P A Sharp; U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

5.  Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification.

Authors:  K R Yamamoto; B M Alberts; R Benzinger; L Lawhorne; G Treiber
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

6.  Complementation analysis of temperature-sensitive host specificity mutations in Escherichia coli.

Authors:  J Hubacek; S W Glover
Journal:  J Mol Biol       Date:  1970-05-28       Impact factor: 5.469

7.  Kinetics of renaturation of DNA.

Authors:  J G Wetmur; N Davidson
Journal:  J Mol Biol       Date:  1968-02-14       Impact factor: 5.469

8.  Human papilloma viruses (HPV): characterization of four different isolates.

Authors:  L Gissmann; H Pfister; H Zur Hausen
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

9.  Human papilloma virus DNA: physical mapping and genetic heterogeneity.

Authors:  L Gissmann; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

10.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  94 in total

1.  Amplification of human papillomavirus DNA sequences by using conserved primers.

Authors:  L Gregoire; M Arella; J Campione-Piccardo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Detection of DNA of human papillomavirus types 6/11 and 16/18 in cell scrapings of the uterine cervix by filter in situ hybridisation. Correlation with cytology, colposcopy and histology.

Authors:  T Demeter; J K Kulski; G F Sterrett; E C Pixley
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

3.  Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas.

Authors:  H Shirasawa; Y Tomita; K Kubota; T Kasai; S Sekiya; H Takamizawa; B Simizu
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 4.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Prevalence of low and high risk human papillomavirus types in cervical cells from Hong Kong pregnant Chinese using filter in situ hybridization.

Authors:  E W Ip; R J Collins; A N Cheung; G Srivastava
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

Review 6.  [Prophylactic and therapeutic HPV immunization].

Authors:  M Müller; L Gissmann
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

7.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Structural analysis of human papillomavirus type 6c isolates from condyloma acuminatum and juvenile-onset and adult-onset laryngeal papillomata.

Authors:  L Metcalfe; S L Chen; P Mounts
Journal:  Virus Genes       Date:  1989-09       Impact factor: 2.332

9.  Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas.

Authors:  T P DiLorenzo; B M Steinberg
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 10.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.